Sustained release heterodisperse hydrogel systems for insoluble drugs
AssigneePenwest Pharmaceuticals Co.
InventorAnand R. Baichwal
Life of this patent
Estimating the term…
Abstract
A sustained release pharmaceutical formulation includes a sustained release excipient including a gelling agent, an inert pharmaceutical diluent, an optional cationic cross-linking agent, and a medicament having moderate to poor solubility is disclosed. In certain embodiments, the sustained release excipient is granulated with a solution or suspension of a hydrophobic polymer in an amount effective to slow the hydration of the gelling agent when the formulation is exposed to an environmental fluid. In another embodiment, the tablet is coated with a hydrophobic polymer.
Claims16
A sustained release oral solid dosage form for providing an effective dose of a medicament having a solubility of less than about 10 g/l over a 24 hour period, comprising
- an effective amount of a medicament to render a therapeutic effect;
- a gelling agent comprising xanthan gum and locust bean gum in a ratio from about 1:3 to about 3:1;
- a pharmaceutically acceptable cationic cross-linking agent capable of cross-linking with said gelling agent and increasing the gel strength when the dosage form is exposed to an environmental fluid;
- and
- an inert pharmaceutical diluent, the ratio of said inert diluent to the total amount of said xanthan gum and said locust bean gum being from about 1:8 to about 8:1;
- wherein said dosage form is a tablet.
A sustained release oral solid dosage form for providing an effective dose of a medicament having a solubility of less than about 10 g/l over a 24 hour period, comprising
- an effective amount of a medicament to render a therapeutic effect;
- a gelling agent comprising xanthan gum and locust bean gum in a ratio from about 1:3 to about 3:1;
- a pharmaceutically acceptable cationic cross-linking agent capable of cross-linking with said gelling agent and increasing the gel strength when the dosage form is exposed to an environmental fluid;
- and
- an inert pharmaceutical diluent, the ratio of said inert diluent to the total amount of said xanthan gum and said locust bean gum being from about 1:8 to about 8:1;
- wherein said dosage form is a tablet coated with a hydrophobic coating to a weight gain from about 1 to about 20 percent of the total weight of said tablet.
Dependencies are inferred from the claim text.